An Open-label Phase 1 Study to Evaluate Pharmacokinetics, Safety, and Tolerability of SY-2101 in Adult Patients with Acute Promyelocytic Leukemia Read more
An Open-Label, Multicenter, Phase 1b/2 Study Of The Safety And Efficacy Of TL-895 Combined With KRT-232 In Subjects With Relapsed/Refractory (R/R) FLT3+ Acute Myeloid Leukemia (AML) Read more
Vyxeos Outpatient Induction Therapy Without Subsequent Planned Admission: A Multicenter Analysis Of Safety And Medical Resource Utilization Read more
Phase IB/II Of CPX-351 As Maintenance Therapy In AML Patients Ineligible For Bone Marrow Transplantation Read more
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study To Assess The Efficacy And Safety Of Entospletinib In Combination With Intensive Induction And Consolidation Chemotherapy In Adults With Actively Diagnosed Nucleophosmin 1-Mutated (NPM1) Acute Myeloid Leukemia Read more
A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of dociparstat sodium in combination with standard chemotherapy for the treatment of ACTIVEly-diagnosed acute myeloid leukemia Read more
